CSL Limited (ASX:CSL)
Australia · Delayed Price · Currency is AUD 175.56
-1.43 (-0.81%)
Nov 5, 2025, 12:58 PM AEST
CSL Limited Market Cap
CSL Limited has a market cap or net worth of 85.55 billion as of November 4, 2025. Its market cap has decreased by -39.34% in one year.
Market Cap
85.55B
Enterprise Value
102.96B
Revenue
23.73B
Ranking
n/a
PE Ratio
18.81
Stock Price
175.56
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 312.00M to 85.55B, an increase of 27,319.21%. That is a compound annual growth rate of 19.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 85.54B | -37.26% |
| Dec 31, 2024 | 136.34B | -1.54% |
| Dec 29, 2023 | 138.48B | -0.20% |
| Dec 30, 2022 | 138.76B | -0.30% |
| Dec 31, 2021 | 139.18B | 8.03% |
| Dec 31, 2020 | 128.84B | 2.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pro Medicus | 27.34B |
| Cochlear | 18.57B |
| Sonic Healthcare | 10.34B |
| Ramsay Health Care | 7.27B |
| Telix Pharmaceuticals | 5.35B |
| Ansell | 5.20B |
| Mesoblast | 3.18B |
| Neuren Pharmaceuticals | 2.65B |